Case Challenges in Hereditary Angioedema: Innovative Therapeutic Strategies for a Normal Life: A Care Team Forum®
Program Overview
Hereditary angioedema (HAE) is a rare disease that causes painful, unpredictable, and potentially life-threatening episodes of subcutaneous or mucosal swelling. Attacks can be a source of stress, anxiety, and may interfere with a person’s ability to live a normal life. In this activity, a patient-provider panel sheds light on the challenges of living with HAE and the promise emerging therapies hold for this patient population.
Allergy/clinical immunology, primary care, and pediatric clinicians
Educational Objectives
Upon completion of this activity, participants should be better able to:
Describe the burden of hereditary angioedema (HAE) and the resulting multifaceted effects that it has on patients’ lives
Integrate objective tools for assessing quality-of-life (QoL) in patients with HAE into clinical practice
Assess the ways novel HAE on-demand and prophylactic therapies may reduce the burden of treatment
Develop individualized HAE treatment plans that result in improved health outcomes and normalization of life
Activity Faculty
Marc A. Riedl, MD, MS
Professor, Medicine
HAE Community Endowed Chair Clinical Director, US HAEA Angioedema Center Clinical Service Chief and Training Program Director, Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA
William R. Lumry, MD
Clinical Professor, Internal Medicine
University of Texas Southwestern Medical School
Dallas, TX